CTIS2023-509383-15-00进行中（未招募）1 期
An intensive program with quadruplet induction and consolidation plus tandem autologous stem cell transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients: a phase II study of the Intergroupe Francophone du Myélome (IFM 2018-04)
Centre Hospitalier Universitaire De Nantes0 个研究点目标入组 50 人开始时间: 2024年6月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Experimental clinical trial regarding relapsing-remitTing Multiple Sclerosis newly diagnosed patients, not yet treated for the evaluation of the onset, the efficacy and speed of action of the treatment with BG00012EUCTR2015-000303-21-ITBiogen Idec Italia S.r.l.
进行中（未招募）
1 期
PRECYCLE: Multicenter, randomized phase IV intergroup trial to evaluate the impact of e Health-based patient reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with Palbociclib and an aromatase inhibitor- or Palbociclib and Fulvestrant - PreCycleEUCTR2016-004191-22-DEPalleos healthcare GmbH960
进行中（未招募）
不适用
A study to confirm the effectiveness of 8mg of fesoterodine compared to 4mg fesoterodine in subjects with overactive bladder.Overactive bladderMedDRA version: 14.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2010-024181-22-ITPFIZER INC.1,990
进行中（未招募）
不适用
A study to confirm the effectiveness of 8mg of fesoterodine compared to 4mg fesoterodine in subjects with overactive bladderMedDRA version: 14.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 10038359 - Renal and urinary disordersOveractive BladderEUCTR2010-024181-22-FIPfizer Inc.235 East 42nd Street, New York, NY 100171,990
进行中（未招募）
不适用
A study to confirm the effectiveness of 8mg of fesoterodine compared to 4mg fesoterodine in subjects with overactive bladderMedDRA version: 14.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 10038359 - Renal and urinary disordersOveractive BladderEUCTR2010-024181-22-DEPfizer Inc, 235 East 42nd Street, New York, NY 10017 US1,990